LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Digital Marketing Business for Sale
Farms & Vineyards for Sale
Cleaning & Janitorial Businesses for Sale
Technology Businesses for Sale
Childcare & Educational Businesses for Sale
Coin Laundry & Dry Cleaning Businesses for Sale
Liquor Store Businesses for Sale
Environmental Businesses for Sale
Healthcare & Medical Businesses for Sale
Construction & Landscaping Businesses for Sale
Gas Station & Car Wash Franchises for Sale
Hotel & Motel Franchises for Sale
Pet Franchise Opportunities
Furniture & Home Decor Franchise Opportunities
Restaurant Franchises for Sale
Beauty & Personal Care Franchises for Sale
Bars & Pubs Franchises for Sale
Advertising & Promotional Franchises for Sale
Consultancy & Training Franchise Opportunities
Manufacturing Franchises for Sale
Commercial Spaces for Sale or Lease
Industrial Units for Sale or Rent
Office Spaces for Sale or Rent
Places of Worship for Sale
Apartment Buildings for Sale
Medical Buildings for Sale or Lease
Miscellaneous Properties for Sale or Lease
Office Buildings for Sale or Rent
Medical Office Spaces for Sale or Rent
Mixed Use Buildings for Sale or Rent
An email will be sent to registered email address.
Please select if you are: